Healthcare provider profile · identity verified

Onalee Jean Hendrickson

Nurse Practitioner · BATH, NY · NPI 1548771108

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	266	97
Lisinopril	Lisinopril	207	63
Levothyroxine Sodium	Levothyroxine Sodium	202	59
Amlodipine Besylate	Amlodipine Besylate	194	57
Metoprolol Succinate	Metoprolol Succinate	186	64
Omeprazole	Omeprazole	153	48
Sertraline Hcl	Sertraline Hcl	146	33
Eliquis	Apixaban	136	23
Losartan Potassium	Losartan Potassium	126	45
Gabapentin	Gabapentin	122	43
Pantoprazole Sodium	Pantoprazole Sodium	105	36
Simvastatin	Simvastatin	89	33
Rosuvastatin Calcium	Rosuvastatin Calcium	87	29
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	86	30
Metformin Hcl	Metformin Hcl	83	33
Tamsulosin Hcl	Tamsulosin Hcl	82	28
Torsemide	Torsemide	76	25
Oxycodone Hcl	Oxycodone Hcl	75	17
Furosemide	Furosemide	70	28
Famotidine	Famotidine	69	28
Citalopram Hbr	Citalopram Hydrobromide	59	13
Escitalopram Oxalate	Escitalopram Oxalate	56	12
Montelukast Sodium	Montelukast Sodium	56	21
Fluticasone Propionate	Fluticasone Propionate	55	29
Metoprolol Tartrate	Metoprolol Tartrate	55	20
Albuterol Sulfate Hfa	Albuterol Sulfate	54	26
Ezetimibe	Ezetimibe	53	23
Allopurinol	Allopurinol	51	21
Bupropion Xl	Bupropion Hcl	49	12
Hydrochlorothiazide	Hydrochlorothiazide	49	17
Alendronate Sodium	Alendronate Sodium	48	13
Alprazolam	Alprazolam	48	19
Mirtazapine	Mirtazapine	48	11
Venlafaxine Hcl Er	Venlafaxine Hcl	48	14
Xarelto	Rivaroxaban	44	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	42	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	41	suppressed
Buspirone Hcl	Buspirone Hcl	39	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	38	13
Trazodone Hcl	Trazodone Hcl	38	15
Doxycycline Hyclate	Doxycycline Hyclate	37	31
Carvedilol	Carvedilol	36	suppressed
Meloxicam	Meloxicam	36	suppressed
Ozempic	Semaglutide	36	suppressed
Warfarin Sodium	Warfarin Sodium	36	13
Duloxetine Hcl	Duloxetine Hcl	35	12
Tramadol Hcl	Tramadol Hcl	35	14
Clopidogrel	Clopidogrel Bisulfate	33	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	32	18
Entresto	Sacubitril/Valsartan	32	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	30	suppressed
Glipizide	Glipizide	30	12
Topiramate	Topiramate	30	suppressed
Atenolol	Atenolol	29	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	29	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Glimepiride	Glimepiride	28	suppressed
Potassium Chloride	Potassium Chloride	27	11
Prednisone	Prednisone	27	18
Jardiance	Empagliflozin	25	suppressed
Pravastatin Sodium	Pravastatin Sodium	25	11
Amitriptyline Hcl	Amitriptyline Hcl	24	suppressed
Pregabalin	Pregabalin	24	suppressed
Spironolactone	Spironolactone	24	suppressed
Azithromycin	Azithromycin	23	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	23	suppressed
Celecoxib	Celecoxib	22	suppressed
Cephalexin	Cephalexin	22	19
Clonazepam	Clonazepam	22	suppressed
Divalproex Sodium	Divalproex Sodium	21	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	14
Enalapril Maleate	Enalapril Maleate	20	suppressed
Januvia	Sitagliptin Phosphate	20	suppressed
Levetiracetam	Levetiracetam	20	suppressed
Ropinirole Hcl	Ropinirole Hcl	20	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	20	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Trospium Chloride	Trospium Chloride	19	suppressed
Baclofen	Baclofen	18	suppressed
Glipizide Er	Glipizide	18	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Tizanidine Hcl	Tizanidine Hcl	18	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Labetalol Hcl	Labetalol Hcl	16	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Lorazepam	Lorazepam	16	suppressed
Memantine Hcl	Memantine Hcl	16	suppressed
Morphine Sulfate Er	Morphine Sulfate	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	15
Trulicity	Dulaglutide	16	suppressed
Azathioprine	Azathioprine	15	suppressed
Benztropine Mesylate	Benztropine Mesylate	15	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	15	suppressed
Nystatin	Nystatin	15	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	15	suppressed
Tresiba Flextouch U-100	Insulin Degludec	15	suppressed
Carbamazepine Er	Carbamazepine	14	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Meclizine Hcl	Meclizine Hcl	14	suppressed
Nitroglycerin	Nitroglycerin	14	suppressed
Tresiba Flextouch U-200	Insulin Degludec	14	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Eszopiclone	Eszopiclone	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Morphine Sulfate	Morphine Sulfate	13	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	13	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Latanoprost	Latanoprost	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Donepezil Hcl	Donepezil Hcl	11	suppressed
Finasteride	Finasteride	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed
Unifine Pentips	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error